Optimas Capital LTD Eli Lilly & CO Transaction History

Optimas Capital LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$724.87 - $909.04 $1.46 Million - $1.83 Million	-2,008 Reduced 15.54%	10,914 $9.88 Million
Q1 2024 May 07, 2024	SELL	$592.2 - $792.28 $420,462 - $562,518	-710 Reduced 5.21%	12,922 $10.1 Million
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $1.18 Million - $1.4 Million	-2,254 Reduced 14.19%	13,632 $7.95 Million
Q3 2023 Oct 30, 2023	SELL	$434.7 - $599.3 $652,484 - $899,549	-1,501 Reduced 8.63%	15,886 $8.53 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $2.55 Million - $3.41 Million	7,281 Added 72.05%	17,387 $8.15 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $4.66 Million - $5.47 Million	-15,007 Reduced 59.76%	10,106 $3.47 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $772,684 - $900,332	2,403 Added 10.58%	25,113 $9.19 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $1.3 Million - $1.48 Million	-4,390 Reduced 16.2%	22,710 $7.34 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $7.55 Million - $8.87 Million	27,100 New	27,100 $8.79 Million

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Optimas Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Optimas Capital LTD with notifications on news.